Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Cervical cancer a major threat to HIV-positive women

HIV-positive women are living longer, but are now dying of cervical cancer. In Zimbabwe, cervical cancer is now the most common cancer among women, particularly those living with HIV. Activists are urging the government to step up efforts to prevent deaths related to the disease, accusing it of paying lip service to the problem.

Published
08 February 2013
From
IRIN Plus News
Vaccine group funds cervical cancer immunizations for poor

The GAVI global vaccines group is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck and GlaxoSmithKline.

Published
04 February 2013
From
Reuters
HIV Patients At Two-Fold Higher Risk For Non-Melanoma Skin Cancers

HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.

Published
31 January 2013
From
HIV / AIDS News From Medical News Today
Cervical Cancer Screening In Less-Developed Areas Should Be Tailored To Local Conditions

The best approach to detecting cervical cancer in HIV-positive women living in research limited countries such as those in Sub-Saharan Africa combines commonly used testing methods tailored to local levels of development and medical infrastructure, according to a study by researchers from and the University of Witwatersrand in South Africa and the University of North Carolina.

Published
16 January 2013
From
HIV / AIDS News From Medical News Today
US research shows that HPV vaccination could prevent pre-cancerous anal cell changes in HIV-positive gay men

Vaccination against cancer-associated strains of human papillomavirus (HPV) could be highly effective at preventing pre-cancerous anal cell changes in men living with HIV, according to research published in

Published
03 January 2013
By
Michael Carter
Liver cancer has a more aggressive disease course in HIV-positive people co-infected with viral hepatitis

Co-infection with HIV and viral hepatitis is associated with a more aggressive disease course for liver cancer, according to research conducted in London and presented to the

Published
18 December 2012
By
Michael Carter
Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising

The investigational cancer drug brivanib did not significantly increase survival for people with hepatocellular carcinoma over existing standard therapy, researchers reported at the recent Liver Meeting 2012,

Published
05 December 2012
By
Liz Highleyman
Nucleoside analogues reduce hepatitis B liver cancer risk

Treatment of chronic hepatitis B with nucleoside analogues including lamivudine (Epivir) and entecavir (Baraclude) can reduce the risk of developing hepatocellular carcinoma, including cancer recurrence after successful resection

Published
29 November 2012
By
Liz Highleyman
Protease inhibitors linked to higher anal cancer rate in US group

Longer treatment with protease inhibitors (PIs) independently raised the anal cancer rate in a study of men and women in California’s Kaiser Permanente healthcare system. Longer antiretroviral use lowered rates of AIDS-defining cancers.

Published
23 November 2012
From
International AIDS Society
HPV vaccine may benefit HIV-infected women

Women with HIV may benefit from a vaccine for human papillomavirus (HPV), despite having already been exposed to HPV, a study finds. Although many may have been exposed to less serious forms of HPV, more than 45 percent of sexually active young women who have acquired HIV appear never to have been exposed to the most common high-risk forms of HPV.

Published
09 November 2012
From
NIH press release
← First12345...26Next →

Filter by country